person

Ake O.

Country
Sweden
Department
N/A

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
883
Sites with multiple studies

Has run more than one trial at 883 of 1740 partner sites.

Specializations

Cardiovascular Medicine

This investigator specializes in various cardiovascular conditions, with particular focus on atherosclerotic cardiovascular disease (ASCVD) and heart failure management.

  • Primary and secondary ASCVD prevention
  • Heart failure with reduced ejection fraction
  • Hypertrophic cardiomyopathy
  • Atrial fibrillation management

Research encompasses innovative therapeutic approaches for cardiovascular risk reduction and heart failure prevention.

Metabolic Disorders

The investigator has significant expertise in treating metabolic conditions, particularly focusing on lipid disorders and their management.

  • Severe hypertriglyceridemia
  • Moderate to severe hypertriglyceridemia
  • Lipid-lowering therapeutics

Therapeutic interests include novel approaches to managing complex lipid disorders and their cardiovascular implications.

Neurological Conditions

Expertise extends to neurological disorders, with particular emphasis on migraine management and treatment innovations.

  • Acute migraine treatment
  • Migraine prevention
  • Treatment-resistant migraine

Focus includes both acute intervention and preventive approaches for migraine disorders.

Respiratory Medicine

The investigator has extensive experience in treating chronic obstructive pulmonary disease (COPD) and its complications.

  • Moderate to severe COPD
  • COPD exacerbation management
  • Combination therapy approaches

Research interests include innovative therapeutic combinations for COPD management.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.